Infection in Nile Tilapia (): A Review

Overview

Journal Biology (Basel)

Publisher MDPI

Specialty Biology

Date 2024 Nov 27

PMID 39596869

Authors

Ebtsam Sayed Hassan Abdallah

Walaa Gomaa Mohamed Metwally

Mootaz Ahmed Mohamed Abdel-Rahman

Marco Albano

Mahmoud Mostafa Mahmoud

Affiliations

Soon will be listed here.

Abstract

(Group B Lancefield) has emerged as a significant pathogen affecting both humans and animals, including aquatic species. Infections caused by are becoming a growing concern in aquaculture and have been reported globally in various freshwater and marine fish species, particularly those inhabiting warm water environments. This has led to numerous outbreaks with high morbidity and mortality in fish. Nile tilapia (), a member of the Cichlid family, is one of the severely affected fish species by The current study aims to focus on infection in cultured with reference to its transmission and sources of infection; risk factors influencing GBS infection, disease clinical signs, lesions, and pathogenesis; virulence factors; and how to diagnose, treat, control, and prevent infection including vaccination and herbal extract medication.

References

Delamare-Deboutteville J, Bowater R, Condon K, Reynolds A, Fisk A, Aviles F . Infection and pathology in Queensland grouper, Epinephelus lanceolatus, (Bloch), caused by exposure to Streptococcus agalactiae via different routes. J Fish Dis. 2014; 38(12):1021-35. DOI: 10.1111/jfd.12273. View

Srisapoome P, Areechon N . Efficacy of viable Bacillus pumilus isolated from farmed fish on immune responses and increased disease resistance in Nile tilapia (Oreochromis niloticus): Laboratory and on-farm trials. Fish Shellfish Immunol. 2017; 67:199-210. DOI: 10.1016/j.fsi.2017.06.018. View

Xia F, Mallet A, Caliot E, Gao C, Trieu-Cuot P, Dramsi S . Capsular polysaccharide of Group B Streptococcus mediates biofilm formation in the presence of human plasma. Microbes Infect. 2014; 17(1):71-76. DOI: 10.1016/j.micinf.2014.10.007. View

Hernandez E, Figueroa J, Iregui C . Streptococcosis on a red tilapia, Oreochromis sp., farm: a case study. J Fish Dis. 2009; 32(3):247-52. DOI: 10.1111/j.1365-2761.2008.00981.x. View

Le Doare K, Heath P . An overview of global GBS epidemiology. Vaccine. 2013; 31 Suppl 4:D7-12. DOI: 10.1016/j.vaccine.2013.01.009. View

Rubens C, Wessels M, Heggen L, Kasper D . Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A. 1987; 84(20):7208-12. PMC: 299259. DOI: 10.1073/pnas.84.20.7208. View

Facimoto C, Chideroli R, Goncalves D, do Carmo A, Kalaphotakis E, de Padua Pereira U . Whole-Genome Sequence of Strain S13, Isolated from a Fish Eye from a Nile Tilapia Farm in Southern Brazil. Genome Announc. 2017; 5(35). PMC: 5578858. DOI: 10.1128/genomeA.00917-17. View

Nizet V . Streptococcal beta-hemolysins: genetics and role in disease pathogenesis. Trends Microbiol. 2003; 10(12):575-80. DOI: 10.1016/s0966-842x(02)02473-3. View

Barato P, Martins E, Melo-Cristino J, Iregui C, Ramirez M . Persistence of a single clone of Streptococcus agalactiae causing disease in tilapia (Oreochromis sp.) cultured in Colombia over 8 years. J Fish Dis. 2015; 38(12):1083-7. DOI: 10.1111/jfd.12337. View

10.

Nguyen N, Warnow T, Pop M, White B . A perspective on 16S rRNA operational taxonomic unit clustering using sequence similarity. NPJ Biofilms Microbiomes. 2017; 2:16004. PMC: 5515256. DOI: 10.1038/npjbiofilms.2016.4. View

11.

Johri A, Paoletti L, Glaser P, Dua M, Sharma P, Grandi G . Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol. 2006; 4(12):932-42. PMC: 2742968. DOI: 10.1038/nrmicro1552. View

12.

Vendrell D, Balcazar J, Ruiz-Zarzuela I, de Blas I, Girones O, Muzquiz J . Lactococcus garvieae in fish: a review. Comp Immunol Microbiol Infect Dis. 2006; 29(4):177-98. DOI: 10.1016/j.cimid.2006.06.003. View

13.

Cabello F . Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol. 2006; 8(7):1137-44. DOI: 10.1111/j.1462-2920.2006.01054.x. View

14.

Slotved H, Kong F, Lambertsen L, Sauer S, Gilbert G . Serotype IX, a Proposed New Streptococcus agalactiae Serotype. J Clin Microbiol. 2007; 45(9):2929-36. PMC: 2045254. DOI: 10.1128/JCM.00117-07. View

15.

Li Y, Liu L, Huang P, Fang W, Luo Z, Peng H . Chronic streptococcosis in Nile tilapia, Oreochromis niloticus (L.), caused by Streptococcus agalactiae. J Fish Dis. 2013; 37(8):757-63. DOI: 10.1111/jfd.12146. View

16.

Abdallah E, Metwally W, Bayoumi S, Abdel Rahman M, Mahmoud M . Isolation and characterization of Streptococcus agalactiae inducing mass mortalities in cultured Nile tilapia (Oreochromis niloticus) with trials for disease control using zinc oxide nanoparticles and ethanolic leaf extracts of some medicinal plants. BMC Vet Res. 2024; 20(1):468. PMC: 11475875. DOI: 10.1186/s12917-024-04298-z. View

17.

Lang S, Palmer M . Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. J Biol Chem. 2003; 278(40):38167-73. DOI: 10.1074/jbc.M303544200. View

18.

Defoirdt T, Sorgeloos P, Bossier P . Alternatives to antibiotics for the control of bacterial disease in aquaculture. Curr Opin Microbiol. 2011; 14(3):251-8. DOI: 10.1016/j.mib.2011.03.004. View

19.

Owatari M, Cardoso L, Pereira S, de Padua Pereira U, Tachibana L, Martins M . Laboratory-controlled challenges of streptococcosis in Nile tilapia using the oral route (infected-feed) for infection. Fish Shellfish Immunol. 2021; 120:295-303. DOI: 10.1016/j.fsi.2021.11.039. View

20.

Faria F, Leal C, Carvalho-Castro G, Leite R, Figueiredo H . Carrier state induced by oxytetracycline therapy against streptococcosis in Nile tilapia, Oreochromis niloticus (L.). J Fish Dis. 2013; 37(9):853-7. DOI: 10.1111/jfd.12177. View